Drugs / MnCl2
last change Nov 2023 re-read 2 minutes ago

MnCl2

Developed for
glioblastoma
Investigated by
Beijing Tiantan Hospital

Trials 1 · a red edge is where a trial was stopped

20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT05131711 Nov 2021 → Nov 2022 glioblastoma Beijing Tiantan Hospital Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as MnCl2 “stereotactic radiosurgery and GM-CSF, Sapylin, MnCl2NCT05131711